Device Authority targets a core security gap in healthcare

Tern plc

Legacy medical devices are not disappearing from healthcare networks. Many hospitals still depend on older equipment that remains clinically useful, expensive to replace and difficult to take offline. That reality creates a clear security challenge: connected medical devices need to be protected even when they were not designed for today’s cybersecurity demands.

Device Authority argues that healthcare organisations need an identity-first security strategy to manage this risk. It is not enough to know that a device is connected to a network. Healthcare providers need to know what the device is, whether it can be trusted, whether its credentials are valid and whether it should be allowed to communicate with other systems.

Many legacy medical devices were built before modern security standards became common. Some may lack strong authentication. Others may rely on outdated software, limited update options or weak certificate management. In a hospital setting, these weaknesses can be difficult to fix quickly because the devices may support critical services and cannot always be replaced or patched without affecting clinical operations.

An identity-first approach puts the device itself at the centre of the security model. Each device needs a trusted identity that can be issued, managed, renewed and revoked across its lifecycle. This makes it easier to control access, reduce exposure and support compliance without depending only on network-based defences. It also gives healthcare organisations a more practical way to manage risk across mixed estates of new and old devices.

For Device Authority, the message is commercially relevant. Healthcare is a sector where connected-device security is not optional, but replacement cycles are long and operational disruption carries real consequences.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual interest. The investment will increase Tern’s loan note holding to approximately £290,000, alongside its existing 26.6% equity stake.

Device Authority highlights security risks as AI begins controlling physical machines

Device Authority examines the security risks of AI-controlled machinery and the role of device identity, authentication and access controls in protecting physical equipment.

Talking Medicines targets better pharmaceutical launch results through message analysis

Talking Medicines' Message Resonance Score measures doctors' understanding of pharmaceutical messaging to help companies improve launch strategies.

Device Authority addresses security risks as AI takes control of physical machines

Device Authority's KeyScaler platform supports secure AI-driven automation by helping organisations authenticate connected machines, protect device identities and control access to physical equipment.

Talking Medicines examines factors influencing prescribing decisions

Talking Medicines explains how healthcare professional conversations, clinical considerations and treatment perceptions can provide pharmaceutical companies with deeper insight into prescribing intent beyond traditional campaign metrics.

What HCPs say could reveal prescribing intent

Talking Medicines is using AI to analyse HCP conversations and identify the clinical and practical factors that may influence prescribing intent.

Search